HOME >> BIOLOGY >> NEWS
Link identified between Alzheimer's disease and glaucoma

UK scientists have shown for the first time that key proteins involved in Alzheimer's disease are also implicated in glaucoma, the major cause of irreversible blindness worldwide. Research carried out at the UCL Institute of Ophthalmology and funded by the Wellcome Trust has also shown that novel drugs being trialled for Alzheimer's disease which target this protein may be used to treat glaucoma.

The research team has developed a new technology for visualising nerve cell damage in the retina, known as Detection of Apoptosing Retinal Cells. Using this technology, they demonstrated that the protein beta-amyloid, which causes the so-called "plaque" lesions in the brains of Alzheimer's patients, also leads to nerve cell death in the retina. The research is published online today in the journal Proceedings of the National Academy of Sciences of the USA.

"We've seen for the first time that there is a clear link between what causes Alzheimer's disease and one of the basic mechanisms behind glaucoma," says Dr Francesca Cordeiro from University College London, who led the study. Dr Cordeiro is also a consultant ophthalmologist at the Western Eye Hospital, London, specialising in glaucoma. "However, this doesn't mean that everyone with Alzheimer's will develop glaucoma or vice versa. Glaucoma has a number of risk factors."

Glaucoma affects over half a million in the UK and as many as 65 million people worldwide(1). Little is know about what exactly causes the disease, which causes damage to the optic nerve in the eye; although the disease is traditionally attributed to increased pressure in the eye (known as "intraocular pressure", and clinical treatments attempt to lower this pressure). However a significant number of patients continue to lose vision despite their pressure being well controlled. The new research opens up a new avenue of treatment in glaucoma which does not involve treating intraocular pressure.

Dr Cordeiro and colle
'"/>

Contact: Mike Findlay
m.findlay@wellcome.ac.uk
44-207-611-8612
Wellcome Trust
6-Aug-2007


Page: 1 2

Related biology news :

1. Gene identified for Crohns disease in children
2. New gene mutation identified in common type of dementia
3. Allergy molecule identified
4. Gene responsible for common hearing loss identified for first time
5. Muscle weakness: New mutation identified
6. Tumor vessels identified by unique molecular markers
7. Extra-aggressive form of idiopathic pulmonary fibrosis identified
8. Newly identified mechanism for silencing genes points to possible anti-cancer strategies
9. Pediatric cancer stem cell identified: understanding the origin of ERMS
10. New host species for avian influenza identified
11. Master regulatory gene of epithelial stem cells identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... BioInformatics Inc., ... as Chief Commercial Officer of the life science research and advisory firm. As ... and alignment of all market research and media revenue operations in the company. ...
(Date:2/19/2019)... ... February 18, 2019 , ... ... development solutions for drugs, biologics and consumer health products, today announced that ... partner recognition, the External Business Partner of the Year Award. , The ...
(Date:2/19/2019)... (PRWEB) , ... February 18, 2019 , ... The Idea, Emma came home from her ... web developer dad figured there must be an app out there to make her homework ... app of her own: Emma’s Words. , The idea is simple enough: help children learn ...
Breaking Biology News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... VetStem Biopharma has long been a ... October 2018, VetStem authorized the formation of Personalized Stem Cells, Inc (“PSC”), a human ... data, and FDA filings to launch into human stem cell clinical therapy. PSC ...
(Date:2/16/2019)... ... February 14, 2019 , ... DaVinci is ... capability that also provides the flexibility for users to bring their own data ... a shared workbench to conduct quick analytics on near-real-time data to gain timely ...
(Date:2/14/2019)... EGG HARBOR, N.J. (PRWEB) , ... February 14, ... ... world’s leading provider of helium based leak testing systems for the pharmaceutical, biotechnology ... to guide the company moving forward. Brian Mulhall has been named ...
(Date:2/12/2019)... ... February 12, 2019 , ... Innovaderm Research, ... deal to extend their use of Medrio, the leading provider of eClinical technology ... has been a regular Medrio customer for over nine years, primarily using the ...
Breaking Biology Technology:
Cached News: